$BCRX
BIOCRYST PHARMACEUTICALS INC

2021 Q4 Form 10-Q Financial Statement

#000117184321007570 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $47.16M $40.99M $6.102M
YoY Change 1074.25% 571.81% 243.77%
Cost Of Revenue $419.0K $591.0K $1.517M
YoY Change 423.75% -61.04%
Gross Profit $46.74M $40.40M $4.585M
YoY Change 1086.27% 781.2% 158.31%
Gross Profit Margin 99.11% 98.56% 75.14%
Selling, General & Admin $35.39M $34.99M $17.20M
YoY Change 68.59% 103.5% 46.53%
% of Gross Profit 75.71% 86.61% 375.03%
Research & Development $63.53M $49.97M $30.25M
YoY Change 79.71% 65.22% 20.4%
% of Gross Profit 135.92% 123.68% 659.65%
Depreciation & Amortization $171.0K $229.0K $170.0K
YoY Change -5.0% 34.71% -5.56%
% of Gross Profit 0.37% 0.57% 3.71%
Operating Expenses $98.92M $84.96M $47.44M
YoY Change 75.57% 79.1% 28.72%
Operating Profit -$52.18M -$44.58M -$42.86M
YoY Change -0.43% 4.01% 22.13%
Interest Expense -$19.19M $14.12M $2.927M
YoY Change 215.58% 382.23% -3.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$15.53M -$58.80M -$46.12M
YoY Change -74.33% 27.5% 22.69%
Income Tax $2.253M $0.00
% Of Pretax Income
Net Earnings -$17.78M -$58.80M -$46.12M
YoY Change -70.61% 27.51% 22.67%
Net Earnings / Revenue -37.7% -143.44% -755.74%
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share -$97.76K -$328.3K -$261.3K
COMMON SHARES
Basic Shares Outstanding 179.9M 178.9M 176.6M
Diluted Shares Outstanding 179.1K 176.5K

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $507.6M $199.6M $143.3M
YoY Change 68.99% 39.27% 109.42%
Cash & Equivalents $504.4M $199.6M $96.49M
Short-Term Investments $3.212M $0.00 $46.83M
Other Short-Term Assets $13.33M $13.27M $7.400M
YoY Change 73.13% 79.34% 51.02%
Inventory $15.79M $13.66M $6.241M
Prepaid Expenses
Receivables $29.41M $26.21M $5.422M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $566.1M $252.7M $162.4M
YoY Change 74.84% 55.6% 106.13%
LONG-TERM ASSETS
Property, Plant & Equipment $8.714M $7.829M $7.142M
YoY Change 22.51% 9.62% -4.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.829M $3.000M
YoY Change
Other Assets $6.472M $5.191M $3.646M
YoY Change 70.23% 42.38% -14.11%
Total Long-Term Assets $22.02M $13.02M $13.79M
YoY Change 101.69% -5.58% 17.89%
TOTAL ASSETS
Total Short-Term Assets $566.1M $252.7M $162.4M
Total Long-Term Assets $22.02M $13.02M $13.79M
Total Assets $588.2M $265.8M $176.2M
YoY Change 75.72% 50.81% 94.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.81M $19.69M $11.62M
YoY Change 48.6% 69.53% 15.19%
Accrued Expenses $72.67M $56.31M $30.46M
YoY Change 114.1% 84.85% 22.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.00M $29.90M
YoY Change -100.0% 0.33% 1.36%
Long-Term Debt Due $19.10M
YoY Change 377.5%
Total Short-Term Liabilities $103.7M $133.6M $111.8M
YoY Change -1.83% 19.53% 36.03%
LONG-TERM LIABILITIES
Long-Term Debt $136.1M $132.1M $26.90M
YoY Change 13.65% 390.89% -41.52%
Other Long-Term Liabilities $5.962M $5.035M $3.900M
YoY Change 52.87% 29.1% 10.08%
Total Long-Term Liabilities $136.1M $132.1M $30.80M
YoY Change 13.65% 328.73% 769.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.7M $133.6M $111.8M
Total Long-Term Liabilities $136.1M $132.1M $30.80M
Total Liabilities $239.8M $265.7M $142.6M
YoY Change 6.39% 86.3% 66.37%
SHAREHOLDERS EQUITY
Retained Earnings -$1.208B -$1.190B -$962.9M
YoY Change 17.98% 23.55% 14.91%
Common Stock $1.843M $1.798M $1.766M
YoY Change 4.18% 1.81% 59.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$107.0M -$147.0M $33.64M
YoY Change
Total Liabilities & Shareholders Equity $588.2M $265.8M $176.2M
YoY Change 75.72% 50.81% 94.72%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$17.78M -$58.80M -$46.12M
YoY Change -70.61% 27.51% 22.67%
Depreciation, Depletion And Amortization $171.0K $229.0K $170.0K
YoY Change -5.0% 34.71% -5.56%
Cash From Operating Activities -$32.46M -$23.28M -$38.26M
YoY Change -27.29% -39.16% 38.42%
INVESTING ACTIVITIES
Capital Expenditures -$1.108M -$365.0K -$170.0K
YoY Change 638.67% 114.71% 112.5%
Acquisitions
YoY Change
Other Investing Activities -$10.01M $8.112M -$33.89M
YoY Change -146.42% -123.94% -243.6%
Cash From Investing Activities -$11.12M $7.747M -$34.06M
YoY Change -151.94% -122.75% -244.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 347.4M 4.776M -4.630M
YoY Change 74.7% -203.15% -2536.84%
NET CHANGE
Cash From Operating Activities -32.46M -23.28M -38.26M
Cash From Investing Activities -11.12M 7.747M -34.06M
Cash From Financing Activities 347.4M 4.776M -4.630M
Net Change In Cash 303.8M -10.75M -76.95M
YoY Change 72.99% -86.03% 1853.05%
FREE CASH FLOW
Cash From Operating Activities -$32.46M -$23.28M -$38.26M
Capital Expenditures -$1.108M -$365.0K -$170.0K
Free Cash Flow -$31.35M -$22.91M -$38.09M
YoY Change -29.53% -39.85% 38.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
179936171
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
179791000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179791000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176883000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176883000
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
942000
CY2020Q2 bcrx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
3511000
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
0 USD
us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199597000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
272127000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4296000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2221000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
28239000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26212000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8646000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
13663000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
7039000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8975000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5528000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
252743000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
323800000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7829000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7113000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5191000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3802000 USD
CY2021Q3 us-gaap Assets
Assets
265763000 USD
CY2020Q4 us-gaap Assets
Assets
334715000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-42864000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-125543000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-122352000 USD
CY2021Q3 bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
9000 USD
CY2020Q3 bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
-312000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
19693000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18713000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56308000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33942000 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
25553000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
21670000 USD
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
602000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
150000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1452000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1179000 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
30000000 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
30000000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
133608000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
105654000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5035000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3871000 USD
CY2021Q3 bcrx Future Royalties Payable
FutureRoyaltiesPayable
142114000 USD
CY2020Q4 bcrx Future Royalties Payable
FutureRoyaltiesPayable
124717000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
132050000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
119735000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1798000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1769000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1040769000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1002408000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
114000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1189725000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1023442000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-147044000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-19262000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265763000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
334715000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
40994000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6102000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
110012000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13796000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
591000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6811000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49971000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30245000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
145279000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87610000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34992000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17195000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83431000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46943000 USD
CY2021Q3 bcrx Royalty Expense Reversal Of Expense
RoyaltyExpenseReversalOfExpense
24000 USD
CY2020Q3 bcrx Royalty Expense Reversal Of Expense
RoyaltyExpenseReversalOfExpense
9000 USD
bcrx Royalty Expense Reversal Of Expense
RoyaltyExpenseReversalOfExpense
34000 USD
bcrx Royalty Expense Reversal Of Expense
RoyaltyExpenseReversalOfExpense
78000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
85578000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
48966000 USD
us-gaap Costs And Expenses
CostsAndExpenses
235555000 USD
us-gaap Costs And Expenses
CostsAndExpenses
136148000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44584000 USD
bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
48000 USD
bcrx Interest And Other Income Loss
InterestAndOtherIncomeLoss
8892000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
14115000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2927000 USD
us-gaap Interest Expense
InterestExpense
40514000 USD
us-gaap Interest Expense
InterestExpense
8892000 USD
CY2021Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-111000 USD
CY2020Q3 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-12000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-274000 USD
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
31000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-58801000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-46115000 USD
us-gaap Net Income Loss
NetIncomeLoss
-166283000 USD
us-gaap Net Income Loss
NetIncomeLoss
-122321000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
114000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-30000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58774000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46109000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-166172000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122351000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-330
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-260
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-930
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-750
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179106
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176521
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
178199
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
164127
us-gaap Net Income Loss
NetIncomeLoss
-166283000 USD
us-gaap Net Income Loss
NetIncomeLoss
-122321000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
606000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
568000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26140000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8907000 USD
bcrx Non Cash Interest Expense On Royalty Financing Obligation
NonCashInterestExpenseOnRoyaltyFinancingObligation
24125000 USD
bcrx Non Cash Interest Expense On Royalty Financing Obligation
NonCashInterestExpenseOnRoyaltyFinancingObligation
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
12871000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
bcrx Increase Decrease In Amortization Of Debt Issuance Costs
IncreaseDecreaseInAmortizationOfDebtIssuanceCosts
-556000 USD
bcrx Increase Decrease In Amortization Of Debt Issuance Costs
IncreaseDecreaseInAmortizationOfDebtIssuanceCosts
1061000 USD
bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
35000 USD
bcrx Amortization Of Discount And Premium On Investments
AmortizationOfDiscountAndPremiumOnInvestments
106000 USD
us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-0 USD
us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-630000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
17579000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-16724000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6630000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6241000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3460000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1448000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16692000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6725000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3884000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4400000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
457000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1688000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109698000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92577000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1277000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
359000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
-0 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49818000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
28201000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
21907000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26924000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28270000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
92848000 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 USD
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
14817000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
5000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12250000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1164000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12250000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103829000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70455000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17018000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
274348000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115723000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
203893000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98705000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-19262000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-64284000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
179000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
723000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2177000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5479000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-74988000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-43198000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4574000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7632000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-106075000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-58801000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
27000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1241000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3535000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13029000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-147044000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
38252000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-37599000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-25000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
266000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2754000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3648000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-38607000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
532000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92848000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14817000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3280000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76507000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-46115000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
366000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2873000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
33637000 USD
CY2021Q3 us-gaap Investments
Investments
0 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
28211000 USD
CY2021Q3 bcrx Available For Sale Debt Securities Accrued Interest
AvailableForSaleDebtSecuritiesAccruedInterest
25000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28239000 USD
CY2021Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
3286000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8243000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
6830000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
206000 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
6619000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2555000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
637000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4548000 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
14086000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
7309000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
423000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
270000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
13663000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
7039000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
1000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
1000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
40994000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6102000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
110012000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13796000 USD
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
1492000 USD
us-gaap Advertising Expense
AdvertisingExpense
4696000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
485000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1574000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1418000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
875000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
724000 USD
CY2021Q3 bcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7327000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12403000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5916000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
14115000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
40514000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2927000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
8892000 USD
CY2021Q3 bcrx Amortization Of Debt Financing Costs And Original Issue Discounts
AmortizationOfDebtFinancingCostsAndOriginalIssueDiscounts
158000 USD
bcrx Amortization Of Debt Financing Costs And Original Issue Discounts
AmortizationOfDebtFinancingCostsAndOriginalIssueDiscounts
369000 USD
CY2020Q3 bcrx Amortization Of Debt Financing Costs And Original Issue Discounts
AmortizationOfDebtFinancingCostsAndOriginalIssueDiscounts
381000 USD
bcrx Amortization Of Debt Financing Costs And Original Issue Discounts
AmortizationOfDebtFinancingCostsAndOriginalIssueDiscounts
1061000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1125000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1235000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1452000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5035000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5191000 USD
CY2021Q3 bcrx Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
2328000 USD
CY2020Q4 bcrx Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
2641000 USD
CY2020Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
108096000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26140000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8907000 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
582084
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28472000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16544000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26131000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14154000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:29pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates in the Company’s consolidated financial statements relate to the valuation of stock options, the ORLADEYO royalty financing and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <em style="font: inherit;">not</em> readily apparent from other sources. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y4M24D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.125 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
1306000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1321000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
22044
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.50
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
60420000 USD
CY2021Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized For Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedForRemainderOfFiscalYear
6324000 USD
CY2021Q3 bcrx Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Next Year
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedNextYear
21474000 USD
CY2021Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
16788000 USD
CY2021Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
14020000 USD
CY2021Q3 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
1814000 USD
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
316000
us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
6918000 USD

Files In Submission

Name View Source Status
0001171843-21-007570-index-headers.html Edgar Link pending
0001171843-21-007570-index.html Edgar Link pending
0001171843-21-007570.txt Edgar Link pending
0001171843-21-007570-xbrl.zip Edgar Link pending
bcrx-20210930.xsd Edgar Link pending
bcrx-20210930_cal.xml Edgar Link unprocessable
bcrx-20210930_def.xml Edgar Link unprocessable
bcrx-20210930_lab.xml Edgar Link unprocessable
bcrx-20210930_pre.xml Edgar Link unprocessable
bcrx20210930_10q.htm Edgar Link pending
bcrx20210930_10q_htm.xml Edgar Link completed
exh107_1.jpg Edgar Link pending
exh107_2.jpg Edgar Link pending
ex_299565.htm Edgar Link pending
ex_299566.htm Edgar Link pending
ex_299567.htm Edgar Link pending
ex_299568.htm Edgar Link pending
ex_299569.htm Edgar Link pending
ex_299570.htm Edgar Link pending
ex_299571.htm Edgar Link pending
ex_299598.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending